Cerence (NASDAQ: CRNC) reported Q2 EPS of ($0.02), $0.14 worse than the analyst estimate of $0.12. Revenue for the quarter came in at $64.2 million versus the consensus estimate of $60.71 million.

GUIDANCE:

Cerence sees Q3 2026 EPS of ($0.02)-$0.07, versus the consensus of $0.20. Cerence sees Q3 2026 revenue of $68-72 million, versus the consensus of $68.22 million.

Cerence sees FY2026 EPS of ($0.07)-$0.15, versus the consensus of $0.69. Cerence sees FY2026 revenue of $305-320 million, versus the consensus of $313.9 million.

For earnings history and earnings-related data on Cerence (CRNC) click here.